Keywords
Acute ischemic cerebrovascular disease
Treatment status
Progress
Submitted : 2024-10-14
Accepted : 2024-10-29
Published : 2024-11-13
Abstract
Acute ischemic cerebrovascular disease (AICD) poses a severe threat to human health, characterized by high incidence and disability rates. Western medicine currently offers multiple treatment methods, such as thrombolysis, anticoagulation, and cerebral circulation improvement, while traditional Chinese medicine demonstrates unique advantages in herbal prescriptions, proprietary Chinese medicines, acupuncture, and massage therapies. Integrative treatment approaches combining Chinese and Western medicine have become widespread in clinical practice, yet challenges remain in optimizing specific treatment plans and elucidating mechanisms of action. This paper aims to comprehensively analyze the current status of integrative treatment for AICD, outline its developmental trajectory, and provide insights for enhancing treatment efficacy.
References
Shen HQ, Xiao J, Zhu XF, et al., 2018, Clinical Observation of Danqi Soft Capsules Combined with Edaravone in Patients with Acute Ischemic Cerebrovascular Disease. World Chin Med, 13(12): 94–97 + 101.
Wei L, 2014, Current Status and Progress in the Treatment of Acute Ischemic Cerebrovascular Disease. Med Rev, 20(16): 2948–2950.
Huang G, Ma MM, 2020, Clinical Effect of Statins Before Thrombolysis in First Acute Ischemic Stroke. J Integr Tradit Chin West Med Cardio Cerebrovasc Dis, 18(1): 149–152.
Huang LJ, 2018, Impact of Intravenous Thrombolysis on Neurological Function and Complications in Patients with Acute Cerebral Infarction and Ischemic Cerebrovascular Disease. Chin J Emerg Med, 38(2): 20.
Wang W, Li Y, Xu JH, et al., 2019, Risk Factors Analysis of Early Neurological Deterioration After Intravenous Thrombolysis in Patients with Acute Ischemic Stroke. Chin J Geriatr Cardio Cerebrovasc Dis, 21(6): 618–621.
Wang H, Ji HX, Hong Y, 2019, Effects of Stroke Blood Supplementing and Guiding Formula Combined with Antiplatelet Drugs on Serum HIF-1α, Copeptin, and Caspase-3 in Patients with Acute Ischemic Cerebrovascular Disease. J Integr Tradit Chin West Med Cardio Cerebrovasc Dis, 17(3): 347–351.
Dhand S, O’Connor P, Hughes C, et al., 2020, Acute Ischemic Stroke: Acute Management and Selection for Endovascular Therapy. Semin Intervent Radiol, 37(2): 109–118. https://doi.org/10.1055/s-0040-1709152
Zhang LH, Peng DY, Zhang C, et al., 2018, Efficacy and Safety Analysis of Intravenous Thrombolysis with Alteplase in Acute Cerebral Infarction Patients of Different Ages. Chin J Geriatr Cardio Cerebrovasc Dis, 20(9): 962–965.
Zou HY, 2008, Clinical Analysis of Defibrase in the Treatment of Acute Ischemic Cerebrovascular Disease. Chin Med Guide, 2008(15): 277.
Pan GW, Lv WS, 2000, Defibrase Therapy for Acute Ischemic Cerebrovascular Disease. Guangdong Med J, 2000(2): 168.
Han B, 2022, Analysis of the Effects of Aspirin Combined with Clopidogrel on Neurological Function and Adverse Reactions in Patients with Acute Ischemic Cerebrovascular Disease. Syst Med, 7(19): 136–139.
Gao YY, Yan J, Chai XB, et al., 2021, Observational Efficacy of Dual Loading Dose Clopidogrel Combined with Aspirin in Treating Acute Ischemic Cerebrovascular Disease. Thromb Haemost, 27(4): 612–613.
Yan XL, 2017, Clinical Observation of Combined Treatment with Aspirin and Clopidogrel for Acute Ischemic Cerebrovascular Disease. Electron J Integr Chin West Med Cardio Dis, 5(27): 68–69.
Wang YC, 2017, Clinical Observation of Low Molecular Weight Heparin Calcium Combined with Clopidogrel in Progressive Ischemic Stroke. J Shandong Med Coll, 39(4): 306–308.
Fang M, 2017, Efficacy and Safety of Clopidogrel Combined with Low Molecular Weight Heparin Calcium in Treating Progressive Ischemic Stroke. China Mod Med, 24(11): 134–136.
Zhang YP, 2018, Clinical Observation of Modified Buyang Huanwu Decoction Combined with Edaravone and Low Molecular Weight Heparin Sodium in Progressive Cerebral Infarction. China Mod Drug Appl, 12(19): 78–79.
Fang KY, Fang GH, Kang JQ, et al., 2020, Clinical Effect Analysis of Edaravone Combined with Xuesaitong in Acute Ischemic Cerebrovascular Disease. Northern Pharm J, 17(1): 53–54.
Li GX, Lv Q, Xiao SQ, et al., 2024, Clinical Observation of Modified Guizhi Fuling Pills in Treating Acute Ischemic Stroke—A Review of “Decision Making in Cerebrovascular Disease Treatment”. World Chin Med, 19(15): 2372.
Yuan Z, 2017, Clinical Study of Mailuoning Injection Combined with Cerebrolysin in Treating Acute Ischemic Cerebrovascular Disease. Mod Drug Clin, 32(12): 2363–2366.
Wang JX, 2015, Progress in the Integrative Treatment of Ischemic Stroke. Inner Mongolia J Tradit Chin Med, 34(8): 143 + 147.
Yin SH, Liu S, Niu HM, et al., 2018, Clinical Observation of Xinglou Chengqi Decoction in the Treatment of Phlegm-Heat and Bowel Excess Syndrome in the Acute Phase of Ischemic Stroke. J Integr Tradit Chin West Med Cardio Cerebrovasc Dis, 16(11): 1487–1489.
Liu LP, Chen WQ, Duan WY, et al., 2019, China Cerebrovascular Disease Clinical Management Guideline (Excerpt)—Clinical Management of Ischemic Cerebrovascular Disease. Chin Stroke J, 14(7): 85–102.
Zeng LM, Yang SX, Cui W, et al., 2024, Clinical Efficacy of Xuesaitong Injection Combined with Alteplase in Treating Acute Ischemic Cerebrovascular Disease. Liaoning J Tradit Chin Med, 51(4): 80–83.
Tang H, 2017, Clinical Observation of Integrated Traditional Chinese and Western Medicine in 42 Cases of Acute Ischemic Cerebrovascular Disease. Hunan J Tradit Chin Med, 33(8): 46–47.
Li Y, Feng YM, 2017, Efficacy Observation of Tongxinluo Capsule Combined with Aspirin in the Treatment of Aspirin Resistance in Transient Ischemic Attack. J Tradit Chin Med, 32(9): 1294–1296.
Wu RQ, 2018, Clinical Observation of Integrative Traditional Chinese and Western Medicine in 60 Cases of Acute Ischemic Cerebrovascular Disease. Shenzhen J Integr Tradit Chin West Med, 28(10): 49–51.
Peng HX, Zhang W, Yang Y, et al., 2019, Clinical Analysis of Acupuncture in Treating Acute Ischemic Cerebrovascular Disease. Chin Clin Res, 11(24): 106–108.